MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 126 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,943 | -45.3% | 68,082 | -13.5% | 0.02% | -34.6% |
| Q2 2023 | $18,176 | -57.2% | 78,682 | -55.1% | 0.03% | -53.6% |
| Q1 2023 | $42,488 | +3094.6% | 175,382 | +3727.6% | 0.06% | +2700.0% |
| Q4 2022 | $1,330 | -99.7% | 4,582 | -4.5% | 0.00% | +100.0% |
| Q1 2022 | $471,000 | +132.0% | 4,800 | +100.0% | 0.00% | – |
| Q4 2021 | $203,000 | -85.1% | 2,400 | -86.0% | 0.00% | -100.0% |
| Q3 2021 | $1,365,000 | -73.6% | 17,111 | -67.7% | 0.00% | -66.7% |
| Q2 2021 | $5,161,000 | +28.7% | 52,982 | +54.5% | 0.01% | +20.0% |
| Q1 2021 | $4,010,000 | +6.0% | 34,282 | +0.7% | 0.01% | +25.0% |
| Q4 2020 | $3,783,000 | +46.3% | 34,033 | +56.2% | 0.00% | +33.3% |
| Q3 2020 | $2,586,000 | -68.5% | 21,782 | -69.9% | 0.00% | -57.1% |
| Q2 2020 | $8,197,000 | +363.6% | 72,382 | +173.3% | 0.01% | +250.0% |
| Q1 2020 | $1,768,000 | -78.0% | 26,482 | -69.8% | 0.00% | -77.8% |
| Q4 2017 | $8,040,000 | +40.4% | 87,587 | -31.2% | 0.01% | +28.6% |
| Q3 2017 | $5,725,000 | +367.0% | 127,287 | +68.8% | 0.01% | +250.0% |
| Q2 2017 | $1,226,000 | +37.6% | 75,387 | +30.3% | 0.00% | +100.0% |
| Q1 2017 | $891,000 | +4.1% | 57,875 | +0.7% | 0.00% | 0.0% |
| Q4 2016 | $856,000 | +27.4% | 57,475 | +8.5% | 0.00% | 0.0% |
| Q3 2016 | $672,000 | – | 52,987 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $5,047,000 | 3.31% |
| L1 Capital Pty Ltd | 161,163 | $10,474,000 | 2.05% |
| Avoro Capital Advisors LLC | 1,535,000 | $99,760,000 | 1.84% |
| Affinity Asset Advisors, LLC | 100,000 | $6,499,000 | 1.81% |
| GREAT POINT PARTNERS LLC | 95,500 | $6,207,000 | 1.50% |
| ARMISTICE CAPITAL, LLC | 1,236,000 | $80,328,000 | 1.39% |
| Affinity Asset Advisors, LLC | 75,000 | $4,874,000 | 1.36% |
| MPM BioImpact LLC | 44,747 | $2,908,000 | 0.69% |
| Baker Brothers Advisors | 1,499,213 | $97,434,000 | 0.64% |
| Perceptive Advisors | 331,023 | $21,513,000 | 0.62% |